Please login to the form below
Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma
It’s now easier, faster and more convenient than ever to get the clinical or payer insight you need. Valid Insight’s virtual workshops can provide a cost-and-time effective solution, eliminating the challenges above, without any IT and technology concerns.
Company Details
Valid Insight
+44 (0) 20 3750 9833
Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom
Latest content on this profile
- RWE Blog 4: The place of real-world evidence in the market access strategy
- The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in Real-world challenges and real-world data, understanding the payer's perspective, in Payers use real-world data cautiously, and seeing the views of both advocates and opponents of RWE in Is real-world evidence the holy grail: Finding the balance.
Valid Insight
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use real-world data cautiously. In our third instalment, we’re looking at how to find the right balance in using RWE.
Valid Insight
- RWE Blog 2: Payers use real-world data cautiously
- Following our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in our blog Real-world challenges and real-world data, the second instalment of our four-blog series looks at why payers use real-world data cautiously.
Valid Insight
- RWE Blog 1: Real-world challenges and real-world data
- This is the first of a set of four blogs on real-world data (RWD) and real-world-evidence (RWE), and their role in market access.
Valid Insight
- Valid News, Market Access Insights, Issue 3
- Wherever you are in the world, it’s important to have a holistic view of what’s happening in the market.
Valid Insight
- The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
- The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published the 21st edition of the EML, recommending the inclusion of 28 new medicines.
Valid Insight
